Showing 1 - 10 of 206
The full-text of this article is not currently available in ORA, but you may be able to access the article via the … publisher copy link on this record page. Citation: Bayne, T. & Pacherie, E. (2007). 'Narrators and comparators: the architecture …
Persistent link: https://www.econbiz.de/10009441406
D61; H51; I18. </AbstractSection> Copyright Dabisch et al.; licensee Springer. 2014
Persistent link: https://www.econbiz.de/10010998823
Persistent link: https://www.econbiz.de/10012303603
Patient-reported outcomes (PROs), including resource utilisation, productivity and quality of life, are important outcomes in the field of migraine. Clinical trials have begun to incorporate PROs; however, not all research questions can be answered fully within the framework of a clinical trial...
Persistent link: https://www.econbiz.de/10005243109
Translational research studies often involve a central study (e.g. clinical trial, cohort of patients, etc.) and multiple investigators who are each interested in addressing different research questions using the same patient population. However, it is often impossible for the investigators to...
Persistent link: https://www.econbiz.de/10005246571
Over the last decade, there has been a proliferation in the number of economic evaluations of pharmaceuticals to meet the growing demand for information about the economic benefits of healthcare technologies. The majority of these studies have been commissioned by pharmaceutical companies for...
Persistent link: https://www.econbiz.de/10005449049
Objective: This paper examined the economic cost of male erectile dysfunction (ED) for a hypothetical managed-care (MC) model. Design and Setting: A prevalence-based cost-of-illness approach was used to estimate the direct medical cost for ED treatment. A treatment plan algorithm was developed...
Persistent link: https://www.econbiz.de/10005449082
Background: A number of approaches to conducting economic evaluations could be adopted. However, some decision makers have a preference for wholly stochastic cost-effectiveness analyses, particularly if the sampled data are derived from randomised controlled trials (RCTs). Formal requirements...
Persistent link: https://www.econbiz.de/10005449236
The ideal study design for demonstrating the possible health outcomes and costs associated with a new drug would be a naturalistic prospective study. However, it is not often feasible to derive the required information from scientifically sound prospective studies. In these cases, decision...
Persistent link: https://www.econbiz.de/10005449246
Persistent link: https://www.econbiz.de/10005404793